Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules

PITTSBURGH, Dec. 31 /PRNewswire-FirstCall/ Mylan Inc. (NYSE: MYL) todayannounced that Mylan Pharmaceuticals Inc. has received final approval from theU.S. Food and Drug Administration (FDA) for its Abbreviated New DrugApplication (ANDA) for Balsalazide Disodium Capsules, 750 mg.

Balsalazide Disodium Capsules are the generic version of SalixPharmaceuticals' Colazal(R) Capsules, which had U.S. sales of approximately$130.9 million for the 12 months ending Sept. 30, 2007.

This product will be shipped immediately.

Mylan Inc. is one of the world's leading quality generic and specialtypharmaceutical companies. The Company offers one of the industry's broadestand highest quality product portfolios, a robust product pipeline and a globalcommercial footprint through operations in more than 90 countries. Through itscontrolling interest in Matrix Laboratories Limited, Mylan has direct accessto one of the largest active pharmaceutical ingredient (API) manufacturers inthe world. Dey L.P., Mylan's fully integrated specialty business, provides theCompany with innovative and diversified opportunities in the respiratory andallergy therapeutic areas.

SOURCE Mylan Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...